AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31

Authors: Haq, IU Ramsay, LE Wallis, EJ Isles, CG Ritchie, LD Jackson, PR
Citation: Iu. Haq et al., Population implications of lipid lowering for prevention of coronary heartdisease: data from the 1995 Scottish Health Survey, HEART, 86(3), 2001, pp. 289-295

Authors: Sanmuganathan, PS Ghahramani, P Jackson, PR Wallis, EJ Ramsay, LE
Citation: Ps. Sanmuganathan et al., Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials, HEART, 85(3), 2001, pp. 265-271

Authors: Davies, SJC Jackson, PR Ramsay, LE
Citation: Sjc. Davies et al., Dysfunctional breathing and asthma - Panic disorder needs to be considered, BR MED J, 323(7313), 2001, pp. 631-631

Authors: Lim, J Yang, QP Jones, BE Jackson, PR
Citation: J. Lim et al., DP flow sensor using optical fibre Bragg grating, SENS ACTU-A, 92(1-3), 2001, pp. 102-108

Authors: Jackson, PR Wallis, EJ Haq, IU Ramsay, LE
Citation: Pr. Jackson et al., Statins for primary prevention: at what coronary risk is safety assured?, BR J CL PH, 52(4), 2001, pp. 439-446

Authors: Wallis, EJ Ramsay, LE Haq, IU Ghahramani, P Jackson, PR
Citation: Ej. Wallis et al., Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validation, J HYPERTENS, 19(4), 2001, pp. 691-696

Authors: Jackson, PR Wallis, EJ Ramsay, LE
Citation: Pr. Jackson et al., Prevention of stroke and transient ischaemic attack, LANCET, 358(9283), 2001, pp. 762-762

Authors: Jackson, PR
Citation: Pr. Jackson, Cholesterol-lowering therapy for smokers, LANCET, 357(9260), 2001, pp. 960-960

Authors: Leach, DJ Jackson, PR Wall, TD
Citation: Dj. Leach et al., Realizing the potential of empowerment: the impact of a feedback intervention on the performance of complex technology, ERGONOMICS, 44(9), 2001, pp. 870-886

Authors: Ramsey, LE Sanmuganathan, PS Wallis, EJ Jackson, PR
Citation: Le. Ramsey et al., Aspirin for primary prevention - Treatment policy should be based on all trial evidence, not subgroup analysis, BR MED J, 321(7274), 2000, pp. 1472-1472

Authors: Jackson, PR Wallis, EJ Ramsay, LE
Citation: Pr. Jackson et al., Optimal age for starting lipid lowering treatment - Adjusted data do not justify a lower optimal age, BR MED J, 321(7261), 2000, pp. 637-638

Authors: Wallis, EJ Ramsay, LE Yikona, JINM Jackson, PR
Citation: Ej. Wallis et al., Comparison of methods of estimating coronary risk - Authors did not use latest version of Sheffield table, BR MED J, 321(7254), 2000, pp. 175-176

Authors: Wallis, EJ Ramsay, LE Haq, IU Ghahramani, P Jackson, PR Rowland-Yeo, K Yeo, WW
Citation: Ej. Wallis et al., Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population, BR MED J, 320(7236), 2000, pp. 671-676

Authors: Jackson, PR Ramsay, LE
Citation: Pr. Jackson et Le. Ramsay, Debate: at what level of coronary heart disease risk should a statin be prescribed?, CURR OP LIP, 11(4), 2000, pp. 357-361

Authors: Sprigg, CA Jackson, PR Parker, SK
Citation: Ca. Sprigg et al., Production teamworking: The importance of interdependence and autonomy foremployee strain and satisfaction, HUMAN RELAT, 53(11), 2000, pp. 1519-1543

Authors: Ramsay, LE Wallis, EJ Yeo, WW Jackson, PR
Citation: Le. Ramsay et al., Absolute and relative risk in hypertension, HBK HYPERT, 20, 2000, pp. 43-56

Authors: Haq, IU Ramsay, LE Jackson, PR Wallis, EJ
Citation: Iu. Haq et al., Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methods, QJM-MON J A, 92(7), 1999, pp. 379-385

Authors: Pickin, DM McCabe, CJ Ramsay, LE Payne, N Haq, IU Yeo, WW Jackson, PR
Citation: Dm. Pickin et al., Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment, HEART, 82(3), 1999, pp. 325-332

Authors: Haq, IU Ramsay, LE Yeo, WW Jackson, PR Wallis, EJ
Citation: Iu. Haq et al., Is the Framingham risk function valid for northern European populations? Acomparison of methods for estimating absolute coronary risk in high risk men, HEART, 81(1), 1999, pp. 40-46

Authors: Ramsay, LE Wallis, EJ Haq, IU Jackson, PR Yeo, WW
Citation: Le. Ramsay et al., Policy based on Sheffield table fully satisfies authors' criteria, BR MED J, 318(7191), 1999, pp. 1140-1141

Authors: Ghahramani, P Jackson, PR Tucker, GT
Citation: P. Ghahramani et al., Fraction of dose of drug converted to a metabolite when both compete for metabolism by the same enzyme, BR J CL PH, 47(5), 1999, pp. 578-578

Authors: Nicholson, K Ramsay, LE Haq, IU Wallis, EJ Ghahramani, P Jackson, PR Yeo, WW
Citation: K. Nicholson et al., Factors affecting the acceptance of drug therapy to prevent myocardial infarction, BR J CL PH, 47(5), 1999, pp. 580-580

Authors: Haq, IU Minnis, R Wallis, EJ Palmer, R Yeo, WW Jackson, PR Ramsay, LE
Citation: Iu. Haq et al., Randomized trial of step-3 diet vs simvastatin therapy for reduction in risk of coronary heart disease, BR J CL PH, 47(5), 1999, pp. 597-598

Authors: Rowland, K Yeo, WW Jackson, PR Ramsay, LE
Citation: K. Rowland et al., Effect of diltiazem on the cholesterol-lowering response to simvastatin: aCYP3A4-mediated reaction, BR J CL PH, 47(5), 1999, pp. 598-598

Authors: Wallis, EJ Yeo, WW Jackson, PR Ramsay, LE
Citation: Ej. Wallis et al., Effect on ACE inhibitor cough of replacing the ACE inhibitor with losartan, BR J CL PH, 47(5), 1999, pp. 598-599
Risultati: 1-25 | 26-31